| Chris Demetriou Md Pc | |
|
1205 Franklin Ave Ste 150 Garden City NY 11530-1629 | |
| (516) 222-2269 | |
| (516) 222-2268 |
| Full Name | Chris Demetriou Md Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1205 Franklin Ave, Garden City, New York |
| Authorized Official Name and Position | Veronica Verde (ADMINISTRATOR) |
| Authorized Official Contact | 5166503355 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Chris Demetriou Md Pc 1205 Franklin Ave Ste 150 Garden City NY 11530-1629 Ph: (516) 222-2269 | Chris Demetriou Md Pc 1205 Franklin Ave Ste 150 Garden City NY 11530-1629 Ph: (516) 222-2269 |
| NPI Number | 1386954279 |
|---|---|
| Provider Enumeration Date | 10/14/2010 |
| Last Update Date | 12/16/2021 |
| Medicare PECOS PAC ID | 4284816927 |
|---|---|
| Medicare Enrollment ID | O20110316000777 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386954279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Chris Demetriou |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1194806075 PECOS PAC ID: 1355375841 Enrollment ID: I20050923000604 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Kenneth Levine |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1083677454 PECOS PAC ID: 3274635453 Enrollment ID: I20070219000156 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Maria T Sabatini |
|---|---|
| Provider Type | Practitioner - Pathology |
| Provider Identifiers | NPI Number: 1598827107 PECOS PAC ID: 6800993742 Enrollment ID: I20070529000521 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Daniel J Ulicny |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1043273402 PECOS PAC ID: 1658465109 Enrollment ID: I20070914000564 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Julio K Kim |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1831357698 PECOS PAC ID: 0547336992 Enrollment ID: I20080909000052 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Haseeb Ahmed |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1487917852 PECOS PAC ID: 1850646191 Enrollment ID: I20180611000120 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Joseph A Ilasi |
|---|---|
| Provider Type | Practitioner - Pathology |
| Provider Identifiers | NPI Number: 1740312818 PECOS PAC ID: 2769628452 Enrollment ID: I20180627001360 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Amy Tan |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1932542149 PECOS PAC ID: 7416295969 Enrollment ID: I20190426001050 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
| Provider Name | Jennifer Miller |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1396275269 PECOS PAC ID: 8426416652 Enrollment ID: I20230621001163 |
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
News Archive
Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
International Stem Cell Corporation announced today that the recent action of a federal district judge blocking federal funding of embryonic stem cell research is not expected to have negative effects on ISCO's therapeutic programs using its human parthenogenetic stem cells.
› Verified 7 days ago
Tlc Laser Eye Centers Garden City Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Garden City Plz, Ste. 130, Garden City, NY 11530 Phone: 516-742-2020 | |
Island Wide Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1401 Franklin Ave, Garden City, NY 11530 Phone: 516-877-2626 | |
City Medical Of Upper East Side, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 901 Franklin Ave, Garden City, NY 11530 Phone: 516-620-0894 | |
Advanced Orthopaedic Specialists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 Franklin Ave Ste 215, Garden City, NY 11530 Phone: 516-248-1314 | |
Gi Doc P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1205 Franklin Ave, Garden City, NY 11530 Phone: 516-650-3355 | |
Nyu Langone Ambulatory Care Garden City Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1111 Franklin Ave, Garden City, NY 11530 Phone: 516-742-3100 Fax: 516-240-7839 | |
Devi Medical Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 901 Stewart Ave, Suite 262, Garden City, NY 11530 Phone: 516-222-2727 |